Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03587922

FANTOM Post Market Clinical Trial

Post Market Study of the FANTOM Sirolimus-Eluting Bioresorbable Coronary Scaffold

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
1,500 (estimated)
Sponsor
REVA Medical, Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Post Market study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold

Conditions

Interventions

TypeNameDescription
DEVICEFantomTreatment of den ovo coronary lesions

Timeline

Start date
2018-05-01
Primary completion
2025-05-01
Completion
2025-05-01
First posted
2018-07-16
Last updated
2024-06-14

Locations

10 sites across 3 countries: Austria, Germany, Switzerland

Source: ClinicalTrials.gov record NCT03587922. Inclusion in this directory is not an endorsement.